Exploratory randomized phase II trial for optimizing treatment dosage and duration of adjuvant S‐1 plus oxaliplatin in patients with stage III colon cancer: YCOG1402 (SOAP trial)

INTRODUCTION: Conventionally, the recommended duration of adjuvant chemotherapy of colon cancer had been 6 months. The IDEA Collaboration suggested that shortening capecitabin and oxaliplatin (CAPOX) adjuvant chemotherapy may be possible. S‐1 and oxaliplatin (SOX) treatment is standard treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Suwa, Yusuke, Watanabe, Jun, Suwa, Hirokazu, Ozawa, Mayumi, Momiyama, Masashi, Ishibe, Atsushi, Nagamine, Kotaro, Yamagishi, Shigeru, Ota, Mitsuyoshi, Fukushima, Tadao, Sekido, Hitoshi, Saigusa, Yusuke, Endo, Itaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623943/
https://www.ncbi.nlm.nih.gov/pubmed/37927922
http://dx.doi.org/10.1002/ags3.12687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623943/
https://www.ncbi.nlm.nih.gov/pubmed/37927922
http://dx.doi.org/10.1002/ags3.12687

Ejemplares similares